DSpace Repository

E3 ubiquitin ligases as novel targets for inflammatory diseases

Show simple item record

dc.contributor.author Gaikwad, Anil Bhanudas
dc.date.accessioned 2023-12-20T09:33:01Z
dc.date.available 2023-12-20T09:33:01Z
dc.date.issued 2016-04
dc.identifier.uri https://www.sciencedirect.com/science/article/abs/pii/S1043661816300184
dc.identifier.uri http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13463
dc.description.abstract Ubiquitination is one of the post translational modifications which decide the fate of various proteins in the cells, by either directing them towards proteasomal degradation or participation in several cell signalling pathways. Recently, the role of ubiquitination has been unravelled in pathogenesis and progression of various diseases, where inflammation is critical, like obesity, insulin resistance, atherosclerosis, angiotensin-II induced cardiac inflammation and asthma. E3 ligases are known to be instrumental in regulation of the inflammatory cascade. This review focuses on the role of different E3 ligases in the development of inflammatory diseases and thus may help us to target these E3 ligases in future drug discovery to prevent inflammation. en_US
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.subject Pharmacy en_US
dc.subject Atherosclerosis en_US
dc.subject Drug en_US
dc.title E3 ubiquitin ligases as novel targets for inflammatory diseases en_US
dc.type Article en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account